Project Details
Short title | Targeting Myeloid-Derived Suppressor Cells (MDSCs) and Tumour-Associated Macrophages (TAMs) with the anti-CD33 immunotoxin Gemtuzumab ozogamicin to restore anti-cancer immunuity |
---|---|
Status | Finished |
Effective start/end date | 1/06/19 → 30/11/20 |
Funding
- CHILDREN'S CANCER AND LEUKAEMIA GROUP